Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dettagli Bibliografici
Autore principale:	Hoque, Ismoth Ara
Altri autori:	Azam, Faruque
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2024
Soggetti:	Lung cancer PFS ORR NSCLC subtypes Lungs > Cancer Clinical trials > Statistical methods
Accesso online:	http://hdl.handle.net/10361/23164

Documenti analoghi

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
di: Paul, Pulock
Pubblicazione: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
di: Rahman, Tasnim
Pubblicazione: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Karim, Samia Binte
Pubblicazione: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Flora, Sanzida Alam
Pubblicazione: (2024)

Molecules associated with the development of lung cancer
di: Rahman, Adree, et al.
Pubblicazione: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
di: Das, Reshita
Pubblicazione: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
di: Jeba, Joynob
Pubblicazione: (2017)

A review on targeted therapies for lung cancer
di: Ashraf, Anushey
Pubblicazione: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
di: Razna, Amrin Islam
Pubblicazione: (2019)

Potential of liposomes for the treatment of lung cancer- a review
di: Mim, Shanzida
Pubblicazione: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
di: Tania, Umme
Pubblicazione: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
di: Zangmo, Thinley
Pubblicazione: (2024)

A review on recent advances in drugs for lung cancer treatment
di: Noor, Fouzia
Pubblicazione: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
di: Pial, Sazia Afrin
Pubblicazione: (2018)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
di: Shabnam, Musharrat
Pubblicazione: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
di: Bristy, Israt Zerin
Pubblicazione: (2021)

Immunotherapy in the Management of Lung Cancer
di: Tasnim, Humayra
Pubblicazione: (2022)

Lung cancer detection and classification using machine learning
di: Arefin, Mahbubul, et al.
Pubblicazione: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
di: Mukti, Roushney Fatima, et al.
Pubblicazione: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
di: Nandy, Aditi
Pubblicazione: (2022)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
di: Shobnam, Sohana
Pubblicazione: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
di: Hasan, Sakib
Pubblicazione: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
di: Monayem, Kazi Fahim
Pubblicazione: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
di: Oishy, Jannatun Noor
Pubblicazione: (2024)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
di: F. S. Amaral, André, et al.
Pubblicazione: (2017)

A comparative study of lung cancer prediction using deep learning
di: Mugdho, Aka Mohammad, et al.
Pubblicazione: (2023)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
di: Auvy, Akib Al Mahmud, et al.
Pubblicazione: (2023)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
di: Hossain, Safa Binte
Pubblicazione: (2019)

Deep 3D convolutional neural network in early detection of Lung cancer
di: Hossain, Khandoker Jobayer, et al.
Pubblicazione: (2019)

Statistics and informatics in molecular cancer research

Smart biomedical device to predict lung diseases, COVID-19 and diabetes by using machine learning algorithms
di: Hossain, Ashraful, et al.
Pubblicazione: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
di: Hasan, Amit
Pubblicazione: (2024)

Machine learning as an indicator for breast cancer prediction
di: Shadman, Tahsin Mohammed, et al.
Pubblicazione: (2019)

The uses of bacteria in cancer therapy
di: Saha, Shimul, et al.
Pubblicazione: (2021)

Safety and efficacy of cisplatin combinations with vinorelbine, paclitaxel and gemcitabine – a systematic review and meta-analysis
di: Islam, Inaya
Pubblicazione: (2024)

Cancer risk factors: a critical review
di: Tabassum, Tahsina
Pubblicazione: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
di: Nawar, Anika
Pubblicazione: (2019)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
di: Abir, Shifaty Nur
Pubblicazione: (2024)

Targeting BRAFV600E in the treatment of CRC
di: Roja, Mashwiyat Samrin
Pubblicazione: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
di: Nashrah, Zannatul
Pubblicazione: (2023)